NVO20260702C43
NVO Jul 2 2026 43.00 Call (NVO260702C00043000)
option OPRA

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.